Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis

Schizophrenia Research

Volumn 132, Issue 2-3, 2011, Pages 183-189

  Orikabe, Lina ^a,b   Yamasue, Hidenori ^a,c   Inoue, Hideyuki ^a   Takayanagi, Yoichiro ^b   Mozue, Yuriko ^b   Sudo, Yasuhiko ^b   Ishii, Tatsuji ^b   Itokawa, Masanari ^d   Suzuki, Michio ^e   Kurachi, Masayoshi ^d   Okazaki, Yuji ^b   Kasai, Kiyoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Brain imaging; Human; Medial temporal lobe; Neuroimaging; Psychiatry; Volumetry

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; METHAMPHETAMINE; NEUROLEPTIC AGENT;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN DISEASE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; INTELLIGENCE QUOTIENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; SOCIAL STATUS; TEMPORAL LOBE; VOLUMETRY; WHITE MATTER;

ADULT; AMYGDALA; ANALYSIS OF VARIANCE; BRAIN MAPPING; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; MIDDLE AGED; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 80054073466     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.07.006     Document Type: Article

References (57)

1. Abe O., Yamasue H., Kasai K., Yamada H., Aoki S., Inoue H., Takei K., Suga M., Matsuo K., Kato T., Masutani Y., Ohtomo K. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res. 2010, 181(1):64-70.
2. Alicata D., Chang L., Cloak C., Abe K., Ernst T. Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users. Psychiatry Res. 2009, 174(1):1-8.
3. Andreasen N.C., Olsen S. Negative v positive schizophrenia. Definition and validation. Arch. Gen. Psychiatry 1982, 39(7):789-794.
4. Bartzokis G., Beckson M., Lu P.H., Edwards N., Bridge P., Mintz J. Brain maturation may be arrested in chronic cocaine addicts. Biol. Psychiatry 2002, 51(8):605-611.
5. Bergouignan L., Chupin M., Czechowska Y., Kinkingnéhun S., Lemogne C., Le Bastard G., Lepage M., Garnero L., Colliot O., Fossati P. Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression?. Neuroimage 2009, 45(1):29-37.
6. Brambilla P., Harenski K., Nicoletti M., Sassi R.B., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., Soares J.C. MRI investigation of temporal lobe structures in bipolar patients. J. Psychiatr. Res. 2003, 37(4):287-295.
7. Buffenstein A., Heaster J., Ko P. Chronic psychotic illness from methamphetamine. Am. J. Psychiatry 1999, 156(4):662.
8. Carmichael O.T., Aizenstein H.A., Davis S.W., Becker J.T., Thompson P.M., Meltzer C.C., Liu Y. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage 2005, 27(4):979-990.
9. Chang L., Smith L.M., LoPresti C., Yonekura M.L., Kuo J., Walot I., Ernst T. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res. 2004, 132(2):95-106.
10. Cook C.E., Jeffcoat A.R., Hill J.M., Pugh D.E., Patetta P.K., Sadler B.M., White W.R., Perez-Reyes M. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab. Dispos. 1993, 21(4):717-723.
11. Davatzikos C. Why voxel-based morphometric analysis should be used with great caution when characterizing group differences. Neuroimage 2004, 23(1):17-20.
12. Elman I., Karlsgodt K.H., Gastfriend D.R. Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence. Am. J. Drug Alcohol Abuse 2001, 27(2):193-202.
13. Firbank M.J., Barber R., Burton E.J., O'Brien J.T. Validation of a fully automated hippocampal segmentation method on patients with dementia. Hum. Brain Mapp. 2008, 29(12):1442-1449.
14. Gilbertson M.W., Shenton M.E., Ciszewski A., Kasai K., Lasko N.B., Orr S.P., Pitman R.K. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat. Neurosci. 2002, 5(11):1242-1247.
15. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14(1 Pt 1):21-36.
16. Haile C.N., Kosten T.R., Kosten T.A. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am. J. Drug Alcohol Abuse 2009, 35(3):161-177.
17. Harano M., Uchimura N., Abe H., Ishibashi M., Iida N., Yanagimoto K., Tanaka T., Maeda H., Sora I., Iyo M., Komiyama T., Yamada M., Sekine Y., Inada T., Ozaki N., Ujike H. A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis. Ann. N. Y. Acad. Sci. 2004, 1025:307-315.
18. Hirayasu Y., Shenton M.E., Salisbury D.F., Dickey C.C., Fischer I.A., Mazzoni P., Kisler T., Arakaki H., Kwon J.S., Anderson J.E., Yurgelun-Todd D., Tohen M., McCarley R.W. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am. J. Psychiatry 1998, 155(10):1384-1391.
19. Hollingshead A.d.B. Two Factor Index of Social Position 1957, Yale University, Dept. of Sociology, New Haven, Conn.
20. Hyman S.E. Addiction to cocaine and amphetamine. Neuron 1996, 16(5):901-904.
21. Inoue H., Yamasue H., Tochigi M., Abe O., Liu X., Kawamura Y., Takei K., Suga M., Yamada H., Rogers M.A., Aoki S., Sasaki T., Kasai K. Association between the oxytocin receptor gene and amygdalar volume in healthy adults. Biol. Psychiatry 2010, 68(11):1066-1072.
22. Iwanami A., Kato N., Nakatani Y. P300 in methamphetamine psychosis. Biol. Psychiatry 1991, 30(7):726-730.
23. Keshavan M.S., Dick E., Mankowski I., Harenski K., Montrose D.M., Diwadkar V., DeBellis M. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr. Res. 2002, 58(2-3):173-183.
24. Kishimoto M., Ujike H., Motohashi Y., Tanaka Y., Okahisa Y., Kotaka T., Harano M., Inada T., Yamada M., Komiyama T., Hori T., Sekine Y., Iwata N., Sora I., Iyo M., Ozaki N., Kuroda S. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol. Psychiatry 2008, 63(2):191-196.
25. Kubicki M., Shenton M.E., Salisbury D.F., Hirayasu Y., Kasai K., Kikinis R., Jolesz F.A., McCarley R.W. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 2002, 17(4):1711-1719.
26. Makris N., Gasic G.P., Seidman L.J., Goldstein J.M., Gastfriend D.R., Elman I., Albaugh M.D., Hodge S.M., Ziegler D.A., Sheahan F.S., Caviness V.S., Tsuang M.T., Kennedy D.N., Hyman S.E., Rosen B.R., Breiter H.C. Decreased absolute amygdala volume in cocaine addicts. Neuron 2004, 44(4):729-740.
27. Matsumoto T., Kamijo A., Miyakawa T., Endo K., Yabana T., Kishimoto H., Okudaira K., Iseki E., Sakai T., Kosaka K. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 2002, 97(7):809-817.
28. Matsuoka K., Uno M., Kasai K., Koyama K., Kim Y. Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin. Neurosci. 2006, 60(3):332-339.
29. Matsuzawa D., Hashimoto K., Miyatake R., Shirayama Y., Shimizu E., Maeda K., Suzuki Y., Mashimo Y., Sekine Y., Inada T., Ozaki N., Iwata N., Harano M., Komiyama T., Yamada M., Sora I., Ujike H., Hata A., Sawa A., Iyo M. Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am. J. Psychiatry 2007, 164(7):1105-1114.
30. McKetin R., McLaren J., Lubman D.I., Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006, 101(10):1473-1478.
31. Melo P., Pinazo-Duran M.D., Salgado-Borges J., Tavares M.A. Correlation of axon size and myelin occupancy in rats prenatally exposed to methamphetamine. Brain Res. 2008, 1222:61-68.
32. Moore G.J., Bebchuk J.M., Wilds I.B., Chen G., Manji H.K., Menji H.K. Lithium-induced increase in human brain grey matter. Lancet 2000, 356(9237):1241-1242.
33. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., Koo M.S., Shenton M.E., McCarley R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry 2007, 62(7):773-783.
34. Nelson H.E. National Adult Reading Test (NART) 1982, NFER-Nelson, Windsor, UK.
35. Onitsuka T., Shenton M.E., Kasai K., Nestor P.G., Toner S.K., Kikinis R., Jolesz F.A., McCarley R.W. Fusiform gyrus volume reduction and facial recognition in chronic schizophrenia. Arch. Gen. Psychiatry 2003, 60(4):349-355.
36. Organization W.H. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research 1993, Switzerland, Geneva.
37. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 1962, 10:799-812.
38. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361(9354):281-288.
39. Sato M., Numachi Y., Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr. Bull. 1992, 18(1):115-122.
40. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Takei N., Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 2001, 158(8):1206-1214.
41. Sekine Y., Minabe Y., Ouchi Y., Takei N., Iyo M., Nakamura K., Suzuki K., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Mori N. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am. J. Psychiatry 2003, 160(9):1699-1701.
42. Selemon L.D., Lidow M.S., Goldman-Rakic P.S. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol. Psychiatry 1999, 46(2):161-172.
43. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(9):3908-3913.
44. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49(1-2):1-52.
45. Sim M.E., Lyoo I.K., Streeter C.C., Covell J., Sarid-Segal O., Ciraulo D.A., Kim M.J., Kaufman M.J., Yurgelun-Todd D.A., Renshaw P.F. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology 2007, 32(10):2229-2237.
46. Snyder S.H. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Am. J. Psychiatry 1973, 130(1):61-67.
47. Steen R.G., Mull C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 2006, 188:510-518.
48. Strakowski S.M., Delbello M.P., Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol. Psychiatry 2005, 10(1):105-116.
49. Takayanagi Y., Kawasaki Y., Nakamura K., Takahashi T., Orikabe L., Toyoda E., Mozue Y., Sato Y., Itokawa M., Yamasue H., Kasai K., Kurachi M., Okazaki Y., Matsushita M., Suzuki M. Differentiation of first-episode schizophrenia patients from healthy controls using ROI-based multiple structural brain variables. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(1):10-17.
50. Tanabe J., Tregellas J.R., Dalwani M., Thompson L., Owens E., Crowley T., Banich M. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol. Psychiatry 2009, 65(2):160-164.
51. Tatetsu S., Goto A., Fujiwara T. The Methamphetamine Psychosis 1956, Igaku-shoin, Tokyo.
52. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., London E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 2004, 24(26):6028-6036.
53. Usher J., Leucht S., Falkai P., Scherk H. Correlation between amygdala volume and age in bipolar disorder - a systematic review and meta-analysis of structural MRI studies. Psychiatry Res. 2010, 182(1):1-8.
54. Williams M.T., Brown R.W., Vorhees C.V. Neonatal methamphetamine administration induces region-specific long-term neuronal morphological changes in the rat hippocampus, nucleus accumbens and parietal cortex. Eur. J. Neurosci. 2004, 19(12):3165-3170.
55. Yamasue H., Iwanami A., Hirayasu Y., Yamada H., Abe O., Kuroki N., Fukuda R., Tsujii K., Aoki S., Ohtomo K., Kato N., Kasai K. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res. 2004, 131(3):195-207.
56. Yamasue H., Abe O., Suga M., Yamada H., Inoue H., Tochigi M., Rogers M., Aoki S., Kato N., Kasai K. Gender-common and -specific neuroanatomical basis of human anxiety-related personality traits. Cereb. Cortex 2008, 18(1):46-52.
57. Yamasue H., Kakiuchi C., Tochigi M., Inoue H., Suga M., Abe O., Yamada H., Sasaki T., Rogers M.A., Aoki S., Kato T., Kasai K. Association between mitochondrial DNA 10398A>G polymorphism and the volume of amygdala. Genes Brain Behav. 2008, 7(6):698-704.